Abstract
Plants are an important source of a variety of bioactive compounds with different modes of action. Anti-HIV agents from plant sources can be useful in developing novel therapies for inhibiting HIV infection. Based on the reported anti-HIV activity of plant derived phloroglucinols, several new dimeric phloroglucinols were synthesized in the present study by varying substitution on aromatic ring and at methylene bridge. Some of the synthesized compounds have shown good HIV inhibitory activity in a human CD4+ T cell line (CEM-GFP) infected with HIV-1 NL(4.3) virus isolate. Structure-activity studies indicate that phenyl, 4-benzyloxy-1-phenyl and cyclohexyl substitution at methylene bridge gave compounds with better anti-HIV activity. Compounds 22 and 24 showed highest anti-HIV activity with an IC(50) of 0.28 microM and 2.71 microM, respectively, former was more active than the positive standard AZT in cell based assay.
Copyright 2010 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-HIV Agents / chemical synthesis*
-
Anti-HIV Agents / chemistry
-
Anti-HIV Agents / therapeutic use
-
Biomimetic Materials / chemical synthesis*
-
Biomimetic Materials / chemistry
-
Biomimetic Materials / therapeutic use
-
Dimerization
-
HIV Infections / drug therapy
-
HIV Reverse Transcriptase / antagonists & inhibitors
-
HIV Reverse Transcriptase / metabolism
-
Humans
-
Phloroglucinol / analogs & derivatives*
-
Phloroglucinol / chemical synthesis
-
Phloroglucinol / chemistry*
-
Phloroglucinol / therapeutic use
-
Structure-Activity Relationship
-
Virus Replication / drug effects
Substances
-
1-(3-isopentanoyl-5-((3,5-diisopentanoyl-2,4,6-trihydroxyphenyl)-4-benzyloxyphenylmethyl)-2,4,6-trihydroxyphenyl)-3-methylbutan-1-one
-
1-(3-isopentanoyl-5-((3,5-diisopentanoyl-2,4,6-trihydroxyphenyl)-phenylmethyl)-2,4,6-trihydroxyphenyl)-3-methylbutan-1-one
-
Anti-HIV Agents
-
Phloroglucinol
-
reverse transcriptase, Human immunodeficiency virus 1
-
HIV Reverse Transcriptase